PALO ALTO, Calif.--(BUSINESS WIRE)--Transcripta Bio, a platform drug development biotechnology company that is revolutionizing discovering and developing medicines at unprecedented speed, scale, and ...
PALO ALTO, Calif., May 30, 2025 /PRNewswire/ -- Transcripta Bio today announced a research collaboration with Microsoft Research to accelerate the discovery of disease-gene associations using advanced ...
SOLVE FSHD Announces Strategic Collaboration with Transcripta Bio to Advance Drug Discovery for FSHD
VANCOUVER, British Columbia, March 25, 2025--(BUSINESS WIRE)--SOLVE FSHD, a venture philanthropy organization dedicated to accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD), is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback